Dry Scalp Care

Dry Scalp Care Manufacturers

• Big Lots
  

  ×

  Dry Scalp Care | Big Lots

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info
• Wal-mart Stores, Inc.
  

  ×

  Dry Scalp Care | Preferred Pharmaceuticals, Inc.

  

  ---

  Amoxicillin and clavulanate potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when amoxicillin and clavulanate potassium is administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, amoxicillin and clavulanate potassium should be taken at the start of a meal.

  2.1 Adults

  The usual adult dose is one amoxicillin and clavulanate potassium tablet, 500 mg/125 mg every 12 hours or one amoxicillin and clavulanate potassium tablet, 250 mg/125 mg every 8 hours. For more severe infections and infections of the respiratory tract, the dose should be one amoxicillin and clavulanate potassium tablet, 875 mg/125 mg every 12 hours or one amoxicillin and clavulanate potassium tablet, 500 mg/125 mg every 8 hours. Adults who have difficulty swallowing may be given the 125 mg/5 mL or 250 mg/5 mL suspension in place of the 500 mg/125 mg tablet. The 200 mg/5 mL suspension or the 400 mg/5 mL suspension may be used in place of the 875 mg/125 mg tablet.

  Two 250 mg/125 mg tablets of amoxicillin and clavulanate potassium should not be substituted for one 500 mg/125 mg tablet of amoxicillin and clavulanate potassium. Since both the 250 mg/125 mg and 500 mg/125 mg tablets of amoxicillin and clavulanate potassium contain the same amount of clavulanic acid (125 mg, as the potassium salt), two 250 mg/125 mg tablets are not equivalent to one 500 mg/125 mg tablet of amoxicillin and clavulanate potassium.

  The 250 mg/125 mg tablet of amoxicillin and clavulanate potassium and the 250 mg/62.5 mg chewable tablet should not be substituted for each other, as they are not interchangeable. The 250 mg/125 mg tablet of amoxicillin and clavulanate potassium and the 250 mg/62.5 mg chewable tablet do not contain the same amount of clavulanic acid (as the potassium salt). The 250 mg/125 mg tablet of amoxicillin and clavulanate potassium contains 125 mg of clavulanic acid, whereas the 250 mg/62.5 mg chewable tablet contains 62.5 mg of clavulanic acid.

  2.2 Pediatric Patients

  Based on the amoxicillin component, amoxicillin and clavulanate potassium should be dosed as follows:

  Neonates and Infants Aged < 12 weeks (< 3 months)

  The recommended dose of amoxicillin and clavulanate potassium is 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Experience with the 200 mg/28.5 mg/5 mL formulation in this age group is limited, and thus, use of the 125 mg/31.25 mg/5 mL oral suspension is recommended.

  Patients Aged 12 weeks (3 months) and Older

  See dosing regimens provided in Table 1. The every 12 hour regimen is recommended as it is associated with significantly less diarrhea [see Clinical Studies (14.2)].

  Table 1: Dosing in Patients Aged 12 weeks (3 months) and Older

  * Each strength of suspension of amoxicillin and clavulanate potassium is available as a chewable tablet for use by older children. † Duration of therapy studied and recommended for acute otitis media is 10 days.

  INFECTION

  DOSING REGIMEN

  Every 12 hours

  Every 8 hours

  200 mg/28.5 mg/5 mL or

  400 mg/57 mg/5 mL oral suspension*

  125 mg/31.25 mg/5 mL or 250 mg/62.5 mg/5 mL oral suspension*

  Otitis media†, sinusitis, lower respiratory tract infections, and more severe infections

  45 mg/kg/day every 12 hours

  40 mg/kg/day every 8 hours

  Less severe infections

  25 mg/kg/day every 12 hours

  20 mg/kg/day every 8 hours

  Patients Weighing 40 kg or More

  Pediatric patients weighing 40 kg or more should be dosed according to adult recommendations.

  The 250 mg/125 mg tablet of amoxicillin and clavulanate potassium should not be used until the child weighs at least 40 kg, due to the different amoxicillin to clavulanic acid ratios in the 250 mg/125 mg tablet of amoxicillin and clavulanate potassium (250/125) versus the 250 mg/62.5 mg chewable tablet of amoxicillin and clavulanate potassium (250/62.5).

  2.3 Patients with Renal Impairment

  Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Renal impairment patients with a glomerular filtration rate of < 30 mL/min should not receive the 875 mg/125 mg dose. Patients with a glomerular filtration rate of 10 to 30 mL/min should receive 500 mg/125 mg or 250 mg/125 mg every 12 hours, depending on the severity of the infection. Patients with a glomerular filtration rate less than 10 mL/min should receive 500 mg/125 mg or 250 mg/125 mg every 24 hours, depending on severity of the infection.

  Hemodialysis patients should receive 500 mg/125 mg or 250 mg/125 mg every 24 hours, depending on severity of the infection. They should receive an additional dose both during and at the end of dialysis.

  2.4 Directions for Mixing Oral Suspension

  Prepare a suspension at time of dispensing as follows: Tap bottle until all the powder flows freely. Add approximately 2/3 of the total amount of water for reconstitution (see Table 2 below) and shake vigorously to suspend powder. Add remainder of the water and again shake vigorously.

  Table 2: Amount of Water for Mixing Oral Suspension

  Strength

  Bottle Size

  Amount of Water for Reconstitution

  Contents of Each Teaspoonful (5 mL)

  200 mg/28.5 mg/5 mL

  50 mL

  75 mL

  100 mL

  47 mL

  70 mL

  93 mL

  200 mg amoxicillin and 28.5 mg of clavulanic acid as the potassium salt

  400 mg/57 mg/5 mL

  50 mL

  75 mL

  100 mL

  45 mL

  67 mL

  89 mL

  400 mg amoxicillin and 57 mg of clavulanic acid as the potassium salt

  Note:  Shake oral suspension well before using. Reconstituted suspension must be stored under refrigeration and discarded after 10 days.

  Close
  No Recall

  More Info
• Family Dollar Services, Inc
  

  ×

  Dry Scalp Care | Family Dollar Services, Inc

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info
• Supervalu, Inc
  

  ×

  Dry Scalp Care | Supervalu, Inc

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repoeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info
• Wal-mart Stores, Inc.
  

  ×

  Dry Scalp Care | Pd-rx Pharmaceuticals, Inc.

  

  ---

  2.1 Hypertension

  The recommended initial dose for patients not receiving a diuretic is 2.5 mg once a day. Adjust dose according to blood pressure response. The usual maintenance dosage range is 2.5 mg to 20 mg per day administered as a single dose or in two equally divided doses. In some patients treated once daily, the antihypertensive effect may diminish toward the end of the dosing interval. In such patients, consider an increase in dosage or twice daily administration. If blood pressure is not controlled with ramipril alone, a diuretic can be added.

  2.2 General Dosing Information

  Generally, swallow ramipril capsules whole. The ramipril capsules can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz. (120 mL) of water or apple juice. To be sure that ramipril is not lost when such a mixture is used, consume the mixture in its entirety. The described mixtures can be pre-prepared and stored for up to 24 hours at room temperature or up to 48 hours under refrigeration.

  Concomitant administration of ramipril with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics can lead to increases of serum potassium [see WARNINGS AND PRECAUTIONS (5.8)].

  2.3 Dosage Adjustment

  Renal Impairment

  Establish baseline renal function in patients initiating ramipril usual regimens of therapy with ramipril may be followed in patients with estimated creatinine clearance >40 mL/min. However, in patients with worse impairment, 25% of the usual dose of ramipril is expected to produce full therapeutic levels of ramiprilat [see USE IN SPECIFIC POPULATION (8.6)].

  Hypertension

  For patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg ramipril capsules once daily. Dosage may be titrated upward until blood pressure is controlled or to a maximum total daily dose of 5 mg.

  Volume Depletion or Renal Artery Stenosis

  Blood pressure decreases associated with any dose of ramipril depend, in part, on the presence or absence of volume depletion (e.g., past and current diuretic use) or the presence or absence of renal artery stenosis. If such circumstances are suspected to be present, initiate dosing at 1.25 mg once daily. Adjust dosage according to blood pressure response.

  Close
  No Recall

  More Info
• American Sales Company
  

  ×

  Dry Scalp Care | Foodhold U.s.a. Llx

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info
• Dza Brands, Llc
  

  ×

  Dry Scalp Care | Cintas Corp.

  

  ---

  Directions:

  Wet hands.
  

  Apply product and work into a lather.

  Rinse well and dry hands thoroughly.
  

  Close
  No Recall

  More Info
• Western Family Foods Inc
  

  ×

  Dry Scalp Care | Upsher-smith Laboratories, Inc.

  

  ---

  2.1 Epilepsy

  It is not necessary to monitor topiramate plasma concentrations to optimize Topiramate Tablets therapy.

  On occasion, the addition of Topiramate Tablets to phenytoin may require an adjustment of the dose of phenytoin to achieve optimal clinical outcome. Addition or withdrawal of phenytoin and/or carbamazepine during adjunctive therapy with Topiramate Tablets may require adjustment of the dose of Topiramate Tablets.

  Because of the bitter taste, tablets should not be broken.

  Topiramate Tablets can be taken without regard to meals.

  Monotherapy Use

  Adults and Pediatric Patients 10 Years and Older

  The recommended dose for topiramate monotherapy in adults and pediatric patients 10 years of age and older is 400 mg/day in two divided doses. Approximately 58% of patients randomized to 400 mg/day achieved this maximal dose in the monotherapy controlled trial; the mean dose achieved in the trial was 275 mg/day. The dose should be achieved by titration according to the following schedule (Table 1):

  Table 1: Monotherapy Titration Schedule for Adults and Pediatric Patients 10 years and older Morning Dose Evening Dose Week 1 25 mg 25 mg Week 2 50 mg 50 mg Week 3 75 mg 75 mg Week 4 100 mg 100 mg Week 5 150 mg 150 mg Week 6 200 mg 200 mg

  Children Ages 2 to <10 Years

  Dosing of topiramate as initial monotherapy in children 2 to < 10 years of age with partial onset or primary generalized tonic-clonic seizures was based on a pharmacometric bridging approach [see Clinical Studies (14.1)].

  Dosing in patients 2 to <10 years is based on weight. During the titration period, the initial dose of topiramate should be 25 mg/day administered nightly for the first week. Based upon tolerability, the dosage can be increased to 50 mg/day (25 mg twice daily) in the second week. Dosage can be increased by 25-50 mg/day each subsequent week as tolerated. Titration to the minimum maintenance dose should be attempted over 5-7 weeks of the total titration period. Based upon tolerability and clinical response, additional titration to a higher dose (up to the maximum maintenance dose) can be attempted at 25-50 mg/day weekly increments. The total daily dose should not exceed the maximum maintenance dose for each range of body weight (Table 2).

  Table 2: Monotherapy Target Total Daily Maintenance Dosing for Patients 2 to <10 Years Weight (kg) Total Daily Dose (mg/day)* Minimum Maintenance Dose Total Daily Dose (mg/day)* Maximum Maintenance Dose * Administered in two equally divided doses Up to 11 150 250 12 – 22 200 300 23 – 31 200 350 32 – 38 250 350 Greater than 38 250 400

  Adjunctive Therapy Use

  Adults 17 Years of Age and Over - Partial Onset Seizures, Primary Generalized Tonic-Clonic Seizures, or Lennox-Gastaut Syndrome

  The recommended total daily dose of Topiramate Tablets as adjunctive therapy in adults with partial onset seizures is 200 to 400 mg/day in two divided doses, and 400 mg/day in two divided doses as adjunctive treatment in adults with primary generalized tonic-clonic seizures. It is recommended that therapy be initiated at 25 to 50 mg/day followed by titration to an effective dose in increments of 25 to 50 mg/day every week. Titrating in increments of 25 mg/day every week may delay the time to reach an effective dose. Doses above 400 mg/day (600, 800 or 1,000 mg/day) have not been shown to improve responses in dose-response studies in adults with partial onset seizures. Daily doses above 1,600 mg have not been studied.

  In the study of primary generalized tonic-clonic seizures, the initial titration rate was slower than in previous studies; the assigned dose was reached at the end of 8 weeks [see Clinical Studies (14.1)].

  Pediatric Patients Ages 2-16 Years – Partial Onset Seizures, Primary Generalized Tonic-Clonic Seizures, or Lennox-Gastaut Syndrome

  The recommended total daily dose of Topiramate Tablets as adjunctive therapy for pediatric patients with partial onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome is approximately 5 to 9 mg/kg/day in two divided doses. Titration should begin at 25 mg/day (or less, based on a range of 1 to 3 mg/kg/day) nightly for the first week. The dosage should then be increased at 1- or 2-week intervals by increments of 1 to 3 mg/kg/day (administered in two divided doses), to achieve optimal clinical response. Dose titration should be guided by clinical outcome.

  In the study of primary generalized tonic-clonic seizures, the initial titration rate was slower than in previous studies; the assigned dose of 6 mg/kg/day was reached at the end of 8 weeks [see Clinical Studies (14.1)].

  2.4 Patients with Renal Impairment

  In renally impaired subjects (creatinine clearance less than 70 mL/min/1.73 m2), one-half of the usual adult dose is recommended. Such patients will require a longer time to reach steady-state at each dose.

  2.5 Geriatric Patients (Ages 65 Years and Over)

  Dosage adjustment may be indicated in the elderly patient when impaired renal function (creatinine clearance rate <70 mL/min/1.73 m2) is evident [see Clinical Pharmacology (12.3)].

  2.6 Patients Undergoing Hemodialysis

  Topiramate is cleared by hemodialysis at a rate that is 4 to 6 times greater than a normal individual. Accordingly, a prolonged period of dialysis may cause topiramate concentration to fall below that required to maintain an anti-seizure effect. To avoid rapid drops in topiramate plasma concentration during hemodialysis, a supplemental dose of topiramate may be required. The actual adjustment should take into account 1) the duration of dialysis period, 2) the clearance rate of the dialysis system being used, and 3) the effective renal clearance of topiramate in the patient being dialyzed.

  2.7 Patients with Hepatic Disease

  In hepatically impaired patients, topiramate plasma concentrations may be increased. The mechanism is not well understood.

  Close
  No Recall

  More Info
• Wakefern Food Corp
  

  ×

  Dry Scalp Care | Camber Pharmaceuticals, Inc.

  

  ---

  2.1 Important Administration Instructions
  

  Levetiracetam oral solution is given orally with or without food. The levetiracetam oral solution dosing regimen depends on the indication, age group, dosage form (tablets or oral solution), and renal function.
  Prescribe the oral solution for pediatric patients with body weight ≤ 20 kg. Prescribe the oral solution or tablets for pediatric patients with body weight above 20 kg.
  When using the oral solution in pediatric patients, dosing is weight-based (mg per kg) using a calibrated measuring device (not a household teaspoon or tablespoon).

  
  2.2Dosing forPartial Onset Seizures
  

  Adults 16 Years and Older
  Initiate treatment with a daily dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg. There is no evidence that doses greater than 3000 mg/day confer additional benefit.
  Pediatric Patients
  Dosing information in pediatric patients less than 4 years of age as adjunctive therapy in the treatment of partial onset seizures is approved for UCB, Inc.'s levetiracetam oral solution. However, due to UCB, Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
  4 Years to < 16 Years
  Initiate treatment with a daily dose of 20 mg/kg in 2 divided doses (10 mg/kg twice daily). Increase the daily dose every 2 weeks by increments of 20 mg/kg to the recommended daily dose of 60 mg/kg (30 mg/kg twice daily). If a patient cannot tolerate a daily dose of 60 mg/kg, the daily dose may be reduced. In the clinical trial, the mean daily dose was 44 mg/kg. The maximum daily dose was 3000 mg/day.
  Levetiracetam Oral Solution Weight-Based Dosing Calculation For Pediatric Patients
  The following calculation should be used to determine the appropriate daily dose of oral solution for pediatric patients:
  
                                              Daily dose (mg/kg/day) x patient weight (kg)
  Total daily dose (mL/day) = --------------------------------------------------------
                                                                      100 mg/mL

  2.3 Dosing forMyoclonic Seizures in Patients 12 Years of Age and Older With Juvenile Myoclonic Epilepsy
  

  Initiate treatment with a dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Increase the dosage by 1000 mg/day every 2 weeks to the recommended daily dose of 3000 mg. The effectiveness of doses lower than 3000 mg/day has not been studied.

  
  2.4 Dosing forPrimary Generalized Tonic-Clonic Seizures
  

  Adults 16 Years and Older
  Initiate treatment with a dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Increase  dosage by 1000 mg/day every 2 weeks to the recommended daily dose of 3000 mg. The effectiveness of doses lower than 3000 mg/day has not been adequately studied.
  Pediatric Patients Ages 6 to <16 Years
  Initiate treatment with a daily dose of 20 mg/kg in 2 divided doses (10 mg/kg twice daily). Increase the daily dose every 2 weeks by increments of 20 mg/kg to the recommended daily dose of 60 mg/kg (30 mg/kg twice daily). The effectiveness of doses lower than 60 mg/kg/day has not been adequately studied. Patients with body weight ≤20 kg should be dosed with oral solution. Patients with body weight above 20 kg can be dosed with either tablets or oral solution [see Dosage and Administration (2.1)].

  
  2.5 Dosage Adjustments inAdult Patients with Renal Impairment
  

  Levetiracetam oral solution dosing must be individualized according to the patient’s renal function status. Recommended dosage adjustments for adults are shown in Table 1. In order to calculate the dose recommended for patients with renal impairment, creatinine clearance adjusted for body surface area must be calculated. To do this an estimate of the patient’s creatinine clearance (CLcr) in mL/min must first be calculated using the following formula:

  
  

                                        [140-age (years)] x weight (kg)           (x 0.85

                         CLcr = ---------------------------------------         for female

                                        72 x serum creatinine (mg/dL)              patients)

  
  

          Then CLcr is adjusted for body surface area (BSA) as follows:

                                                        CLcr (mL/min)

             CLcr (mL/min/1.73m2) =    ------------------- x 1.73

                                                        BSA subject (m2)

  
  

  Table 1: Dosing Adjustment Regimen for Adult Patients with Renal Impairment

  Group
  Creatinine Clearance
   (mL/min/1.73m2)
               Dosage (mg)            
  Frequency
  Normal
  > 80
  500 to 1,500
  Every 12 hours
  
   
  Mild
  50 – 80
  500 to 1,000
  Every 12 hours
  Moderate
  30 – 50
  250 to 750
  Every 12 hours
  Severe
  < 30
  250 to 500
  Every 12 hours
  ESRD patients
  using dialysis
  ----
  500 to 1,0001
  12 hours1
  

  1 Following dialysis, a 250 to 500 mg supplemental dose is recommended.

  Close
  No Recall

  More Info
• Safeway, Inc
  

  ×

  Dry Scalp Care | Kmart Corporation

  

  ---

  • this product does not contain directions or complete warnings for adult use • do not give more than directed (see overdose warning) • shake well before using • mL = milliliter; tsp = teaspoonful • find right dose on chart below. If possible, use weight to dose; otherwise, use age. • remove the child protective cap and squeeze your child’s dose into the dosing cup • repeat dose every 4 hours while symptoms last • do not give more than 5 times in 24 hours

  Weight (lb)

  Age (yr)

  Dose (mL or tsp)*

  under 24

  under 2 years

  ask a doctor

  24-35

  2-3 years

  5 mL (1 tsp)

  36-47

  4-5 years

  7.5 mL (1 ½ tsp)

  48-59

  6-8 years

  10 mL (2 tsp)

  60-71

  9-10 years

  12.5 mL (2 ½ tsp)

  72-95

  11 years

  15 mL (3 tsp)

  *or as directed by a doctor

  Attention: use only enclosed dosing cup specifically designed for use with this product. Do not use any other dosing device.

  Close
  No Recall

  More Info
• Cvs Pharmacy, Inc
  

  ×

  Dry Scalp Care | Value Merchandisers Company, Inc.

  

  ---

  this product does not contain directions or complete warnings for adult use find the right dose on chart below. If possible, use weight to dose; otherwise, use age. if needed, repeat dose every 4 hours while symptoms last dissolve in mouth or chew before swallowing do not give more than 5 times in 24 hours do not give for more than 5 days unless directed by a doctor  Weight (lb)  Age (yr) Tablets Under 48 Under 6  Ask a doctor 48-59 6-8 2 60-71 9-10 2 1/2 72-95 11 3
  

  Close
  No Recall

  More Info
• Onpoint, Inc
  

  ×

  Dry Scalp Care | Onpoint, Inc

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repoeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info
• The Kroger Co
  

  ×

  Dry Scalp Care | The Kroger Co

  

  ---

  shake well for maximum dandruff control, use every time you shampoo wet hair, massage onto scalp, rinse, repeat if desired for best results use at least twice a week or as directed by a doctor

  Close
  No Recall

  More Info